JBCHEPHARMPharmaceuticals
JB Chemicals & Pharmaceuticals Ltd — Profit & Loss Statement
₹2064.40
-1.97%
JB Chemicals & Pharmaceuticals Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 8.45 Cr | 8.70 Cr | 1.98 Cr | 0.00 | — |
| Tax Rate For Calcs | 0.26 | 0.26 | 0.26 | 0.24 | — |
| Normalized EBITDA | 1.04K Cr | 900.62 Cr | 697.47 Cr | 582.68 Cr | — |
| Total Unusual Items | 32.90 Cr | 32.87 Cr | 7.57 Cr | 37.45 Cr | — |
| Total Unusual Items Excluding Goodwill | 32.90 Cr | 32.87 Cr | 7.57 Cr | 37.45 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 659.58 Cr | 552.63 Cr | 409.84 Cr | 385.36 Cr | — |
| Reconciled Depreciation | 171.04 Cr | 138.32 Cr | 114.41 Cr | 72.66 Cr | — |
| Reconciled Cost Of Revenue | 1.34K Cr | 1.20K Cr | 1.18K Cr | 842.94 Cr | — |
| EBITDA | 1.07K Cr | 933.48 Cr | 705.05 Cr | 582.68 Cr | — |
| EBIT | 898.08 Cr | 795.16 Cr | 590.64 Cr | 510.02 Cr | — |
| Net Interest Income | -6.40 Cr | -39.90 Cr | -33.52 Cr | -5.12 Cr | — |
| Interest Expense | 10.69 Cr | 43.65 Cr | 35.41 Cr | 5.12 Cr | — |
| Interest Income | 5.33 Cr | 4.43 Cr | 2.54 Cr | 0.93 Cr | — |
| Normalized Income | 635.13 Cr | 528.46 Cr | 404.24 Cr | 385.36 Cr | — |
| Net Income From Continuing And Discontinued Operation | 659.58 Cr | 552.63 Cr | 409.84 Cr | 385.36 Cr | — |
| Total Expenses | 3.01K Cr | 2.70K Cr | 2.53K Cr | 1.95K Cr | — |
| Rent Expense Supplemental | 2.25 Cr | 2.02 Cr | 2.95 Cr | 1.34 Cr | — |
| Diluted Average Shares | 15.87 Cr | 15.86 Cr | 7.83 Cr | 15.47 Cr | — |
| Basic Average Shares | 15.54 Cr | 15.50 Cr | 7.73 Cr | 15.46 Cr | — |
| Diluted EPS | 41.56 | 34.85 | 26.17 | 24.91 | — |
| Basic EPS | 42.45 | 35.66 | 26.50 | 24.93 | — |
| Diluted NI Availto Com Stockholders | 659.58 Cr | 552.63 Cr | 409.84 Cr | 385.36 Cr | — |
| Net Income Common Stockholders | 659.58 Cr | 552.63 Cr | 409.84 Cr | 385.36 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 659.58 Cr | 552.63 Cr | 409.84 Cr | 385.36 Cr | — |
| Minority Interests | 0.00 | 0.00 | -0.17 Cr | -0.68 Cr | — |
| Net Income Including Noncontrolling Interests | 659.58 Cr | 552.63 Cr | 410.01 Cr | 386.04 Cr | — |
| Net Income Continuous Operations | 659.58 Cr | 552.63 Cr | 410.01 Cr | 386.04 Cr | — |
| Tax Provision | 227.81 Cr | 198.88 Cr | 145.23 Cr | 118.86 Cr | — |
| Pretax Income | 887.39 Cr | 751.51 Cr | 555.23 Cr | 504.90 Cr | — |
| Other Non Operating Income Expenses | 0.57 Cr | 0.10 Cr | 0.37 Cr | 39.23 Cr | — |
| Special Income Charges | 0.69 Cr | 0.12 Cr | 0.67 Cr | 2.40 Cr | — |
| Other Special Charges | -0.69 Cr | -0.12 Cr | -0.67 Cr | -2.40 Cr | — |
| Net Non Operating Interest Income Expense | -6.40 Cr | -39.90 Cr | -33.52 Cr | -5.12 Cr | — |
| Total Other Finance Cost | 1.04 Cr | 0.68 Cr | 0.64 Cr | 0.34 Cr | — |
| Interest Expense Non Operating | 10.69 Cr | 43.65 Cr | 35.41 Cr | 5.12 Cr | — |
| Interest Income Non Operating | 5.33 Cr | 4.43 Cr | 2.54 Cr | 0.93 Cr | — |
| Operating Income | 854.52 Cr | 752.63 Cr | 587.49 Cr | 470.79 Cr | — |
| Operating Expense | 1.67K Cr | 1.49K Cr | 1.34K Cr | 1.11K Cr | — |
| Other Operating Expenses | 341.67 Cr | 329.47 Cr | 303.88 Cr | 598.61 Cr | — |
| Depreciation And Amortization In Income Statement | 171.04 Cr | 138.32 Cr | 114.41 Cr | 72.66 Cr | — |
| Depreciation Income Statement | 171.04 Cr | 138.32 Cr | 114.41 Cr | 72.66 Cr | — |
| Selling General And Administration | 466.07 Cr | 415.51 Cr | 375.29 Cr | 316.10 Cr | — |
| Selling And Marketing Expense | 429.82 Cr | 381.81 Cr | 338.50 Cr | 258.11 Cr | — |
| General And Administrative Expense | 36.25 Cr | 33.70 Cr | 36.79 Cr | 57.99 Cr | — |
| Rent And Landing Fees | 2.25 Cr | 2.02 Cr | 2.95 Cr | 1.34 Cr | — |
| Gross Profit | 2.52K Cr | 2.24K Cr | 1.93K Cr | 1.58K Cr | — |
| Cost Of Revenue | 1.34K Cr | 1.20K Cr | 1.18K Cr | 842.94 Cr | — |
| Total Revenue | 3.86K Cr | 3.45K Cr | 3.12K Cr | 2.42K Cr | — |
| Operating Revenue | 3.86K Cr | 3.45K Cr | 3.12K Cr | 2.42K Cr | — |
| Write Off | — | — | — | — | 0.08 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on JB Chemicals & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.